Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Researchers discover breakthrough in ovarian cancer

15.02.2013
Findings from University of Arizona Cancer Center at St. Joseph's

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.

"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.

The Gynecologic Oncology Group is a non-profit international organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies.

Dr. Farley is part of the University of Arizona Cancer Center at St. Joseph's and is board certified in obstetrics and gynecology with a subspecialty certification in gynecologic oncology. He is a retired decorated Army colonel who completed a residency in obstetrics and gynecology and a fellowship in gynecologic oncology at Walter Reed Army Medical Center. He is the first author on this study.

This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.

This study is registered with ClinicalTrials.gov, number NCT00551070.

About The University of Arizona Cancer Center

The University of Arizona Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center headquartered in Arizona. The UACC is supported by NCI Cancer Center Support Grant number CA023074. With primary locations at the University of Arizona in Tucson and at St. Joseph's Hospital and Medical Center in Phoenix, the Cancer Center has more than a dozen research and education offices in Phoenix and throughout the state and 300 physician and scientist members work together to prevent and cure cancer. For more information, go to http://www.arizonacancercenter.org

About St. Joseph's Hospital and Medical Center

Located in the heart of Phoenix, Ariz., St. Joseph's Hospital and Medical Center is a 607-bed, not-for-profit hospital that provides a wide range of health, social and support services with special advocacy for the poor and underserved. St. Joseph's is a nationally recognized center for quality tertiary care, medical education and research. It includes the internationally renowned Barrow Neurological Institute, the Heart & Lung Institute, the Muhammad Ali Parkinson Center, and a Level I Trauma Center verified by the American College of Surgeons. U.S. News & World Report routinely ranks St. Joseph's among the best hospitals in the United States for neurology and neurosurgery.

Lynne Reaves | EurekAlert!
Further information:
http://www.arizonacancercenter.org
http://www.stjosephs-phx.org/index.htm

More articles from Health and Medicine:

nachricht Using DNA origami to build nanodevices of the future
31.08.2015 | Institute for Integrated Cell-Material Sciences at Kyoto University

nachricht An ounce of prevention: Research advances on 'scourge' of transplant wards
28.08.2015 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Elektrofahrzeuge kabellos laden und entladen

Über ein kabelloses Ladesystem können Elektroautos künftig nicht nur tanken, sondern die Energie ins Stromnetz zurückspeisen. Auf diese Weise helfen sie das Netz zu stabilisieren. Das kostengünstige Ladesystem erreicht hohe Wirkungsgrade – über den vollen Leistungsbereich von 400 Watt bis 3,6 Kilowatt. Die Abstände zwischen Auto und Ladespule können bis zu 20 Zentimeter be- tragen. Auf der Internationalen Automobil Ausstellung IAA in Frankfurt stellen Fraunhofer-Forscher den Prototyp vom 15. bis 18. September 2015 vor (Halle 4, Stand D33).

Es regnet in Strömen. Wer jetzt ein dickes unhandliches Kabel zwischen Elektrofahrzeug und Ladesäule einstecken muss, wird patschnass. Doch es nützt nichts,...

Im Focus: Increasingly severe disturbances weaken world's temperate forests

Longer, more severe, and hotter droughts and a myriad of other threats, including diseases and more extensive and severe wildfires, are threatening to transform some of the world's temperate forests, a new study published in Science has found. Without informed management, some forests could convert to shrublands or grasslands within the coming decades.

"While we have been trying to manage for resilience of 20th century conditions, we realize now that we must prepare for transformations and attempt to ease...

Im Focus: Meeresinseln als Heimat einmaliger Pflanzenarten

Warum leben in manchen Ökosystemen auffallend viele, in anderen Ökosystemen nur wenige Pflanzenarten? Wie kommt es, dass einige Arten jeweils nur in einer bestimmten, klar abgrenzbaren Region der Erde zuhause sind? Mit diesen Fragen hat sich Dr. Manuel Steinbauer in einer Reihe wissenschaftlicher Studien an der Universität Bayreuth befasst. Für seine Forschungsarbeiten wird der Bayreuther Ökologe, der zurzeit als Postdoc an der dänischen Universität Aarhus forscht, mit dem diesjährigen Wilhelm Pfeffer-Preis der Deutschen Botanischen Gesellschaft (DBG) ausgezeichnet. Der Preis ist mit 2.500 Euro dotiert.

Wenn es darum geht, den Gründen für die Verbreitung pflanzlicher Arten auf die Spur zu kommen und theoretische Erklärungsansätze zu überprüfen, sind...

Im Focus: OU astrophysicist and collaborators find supermassive black holes in quasar nearest Earth

A University of Oklahoma astrophysicist and his Chinese collaborator have found two supermassive black holes in Markarian 231, the nearest quasar to Earth, using observations from NASA's Hubble Space Telescope.

The discovery of two supermassive black holes--one larger one and a second, smaller one--are evidence of a binary black hole and suggests that supermassive...

Im Focus: Optische Schalter - Lernen mit Licht

Einem deutsch-französischen Team ist es gelungen, einen lichtempfindlichen Schalter für Nervenzellen zu entwickeln. Dies ermöglicht neue Einblicke in die Funktionsweise von Gedächtnis und Lernen, aber auch in die Entstehung von Krankheiten.

Lernen ist nur möglich, weil die Verknüpfungen zwischen den Nervenzellen im Gehirn fortwährend umgebaut werden: Je häufiger bestimmte Reizübertragungswege...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Frankfurter Hochhausfassadentage 2015: Frankfurt UAS veranstaltet Symposium und Hochhausführung

31.08.2015 | Veranstaltungen

Erreger unter Superlupen – Aufbruch in unsichtbare Welten

31.08.2015 | Veranstaltungen

Fehlermeldungen des Gehirns auf der Spur

31.08.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Fehlgeleitete Galileo-Satelliten für Forschungsmission freigegeben

31.08.2015 | Geowissenschaften

Frankfurter Hochhausfassadentage 2015: Frankfurt UAS veranstaltet Symposium und Hochhausführung

31.08.2015 | Veranstaltungsnachrichten

Siemens-Lösungen unterstützen Diagnose und Therapie kardiovaskulärer Erkrankungen

31.08.2015 | Messenachrichten